Stockholders’ Equity |
6 Months Ended |
|---|---|
Mar. 29, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Equity | Note 7 - Stockholders’ Equity
Dividends
No dividends were declared or paid during the three and six months ended March 29, 2026 or the twelve months ended September 28, 2025.
Common stock
During the six months ended March 29,2026, the Company issued restricted shares to four board members which will vest on January 1, 2027.
During the six months ended March 30, 2025, the Company issued restricted shares to three independent board members which vested on January 1,2026.
On February 9, 2026, the Board of Directors of the Company terminated the Company’s existing stock repurchase program and approved a new stock repurchase program pursuant to which the Company may purchase up to $10,000,000 in shares of the Company’s outstanding common stock (the “Repurchase Program”). The Repurchase Program allows the Company to purchase common stock from time to time through, among other methods, open market purchases, privately negotiated transactions, and/or pursuant to Rule 10b5-1 trading plans, subject to applicable securities laws and other legal requirements and relevant factors. The number of shares purchased and the timing of any purchases will depend upon a number of factors, including the price and availability of the Company’s common stock and general market conditions. The Repurchase Program may be modified, suspended or terminated at any time, without prior notice. During the three and six months ended March 29, 2026 and March 30, 2025, there were no stock repurchases under the Repurchase Program.
As of March 29, 2026 and September 28, 2025, the total issued and outstanding common shares were and , respectively.
|